BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 8990091)

  • 21. New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus.
    Putterman C
    Autoimmun Rev; 2004 Feb; 3(2):7-11. PubMed ID: 15003182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-reaction of lupus anti-dsDNA antibodies with protein translation factor EF-2.
    Alberdi F; Dadone J; Ryazanov A; Isenberg DA; Ravirajan C; Reichlin M
    Clin Immunol; 2001 Feb; 98(2):293-300. PubMed ID: 11161987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.
    Friedmann D; Yachimovich N; Mostoslavsky G; Pewzner-Jung Y; Ben-Yehuda A; Rajewsky K; Eilat D
    J Immunol; 1999 Apr; 162(8):4406-16. PubMed ID: 10201976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice.
    Roark JH; Kuntz CL; Nguyen KA; Mandik L; Cattermole M; Erikson J
    J Immunol; 1995 May; 154(9):4444-55. PubMed ID: 7722301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
    Mason LJ; Ravirajan CT; Rahman A; Putterman C; Isenberg DA
    Arthritis Rheum; 2004 Mar; 50(3):866-70. PubMed ID: 15022329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initiation of systemic autoimmunity and sequence specific anti-DNA autoantibodies.
    Radic MZ; Cocca BA; Seal SN
    Crit Rev Immunol; 1999; 19(2):117-26. PubMed ID: 10352900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19.
    Taylor DK; Ito E; Thorn M; Sundar K; Tedder T; Spatz LA
    Mol Immunol; 2006 Apr; 43(11):1776-90. PubMed ID: 16430962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-cell anergy is maintained in anti-DNA transgenic NZB/NZW mice.
    Kat I; Makdasi E; Fischel R; Eilat D
    Int Immunol; 2010 Feb; 22(2):101-11. PubMed ID: 20038519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mimotopes of polyreactive anti-DNA antibodies identified using phage-display peptide libraries.
    Sibille P; Ternynck T; Nato F; Buttin G; Strosberg D; Avrameas A
    Eur J Immunol; 1997 May; 27(5):1221-8. PubMed ID: 9174614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion and editing of B cells that express antibodies to DNA.
    Chen C; Radic MZ; Erikson J; Camper SA; Litwin S; Hardy RR; Weigert M
    J Immunol; 1994 Feb; 152(4):1970-82. PubMed ID: 8120401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles.
    Cambridge G; Leandro MJ; Teodorescu M; Manson J; Rahman A; Isenberg DA; Edwards JC
    Arthritis Rheum; 2006 Nov; 54(11):3612-22. PubMed ID: 17075806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice.
    Erikson J; Radic MZ; Camper SA; Hardy RR; Carmack C; Weigert M
    Nature; 1991 Jan; 349(6307):331-4. PubMed ID: 1898987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bcl-2 leads to expression of anti-DNA B cells but no nephritis: a model for a clinical subset.
    Kuo P; Bynoe MS; Wang C; Diamond B
    Eur J Immunol; 1999 Oct; 29(10):3168-78. PubMed ID: 10540328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies.
    Riemekasten G; Langnickel D; Ebling FM; Karpouzas G; Kalsi J; Herberth G; Tsao BP; Henklein P; Langer S; Burmester GR; Radbruch A; Hiepe F; Hahn BH
    Arthritis Rheum; 2003 Feb; 48(2):475-85. PubMed ID: 12571858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice.
    Fish F; Ziff M
    J Immunol; 1982 Jan; 128(1):409-14. PubMed ID: 6976378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenic properties of an anti-DNA antibody-derived peptide, 88H.64-80: location of a dominant idiotope defined by T and B cells.
    Ward FJ; Khan N; Wolger LJ; Howe CA; Eivazova ER; Harper N; Muller S; Staines NA
    J Autoimmun; 1998 Oct; 11(5):439-47. PubMed ID: 9802927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-DNA knock-in model of systemic autoimmunity induced by the chronic graft-vs-host reaction.
    Eisenberg R; Choudhury A
    Methods Mol Med; 2004; 102():273-84. PubMed ID: 15286390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity.
    Mason LJ; Lambrianides A; Haley JD; Manson JJ; Latchman DS; Isenberg DA; Rahman A
    Arthritis Res Ther; 2005; 7(5):R971-83. PubMed ID: 16207338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of anti-double stranded DNA idiotype in mixed connective tissue disease and progressive systemic sclerosis.
    Kubota T; Kanai Y
    Bull Tokyo Med Dent Univ; 1989 Jun; 36(2):13-8. PubMed ID: 2789110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies, lupus and the science of sabotage.
    Rahman A
    Rheumatology (Oxford); 2004 Nov; 43(11):1326-36. PubMed ID: 15328419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.